Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
83.50    -0.50 (-0.60%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £12.11m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Acquisition

6 Feb 2007 07:00

Adventis Group PLC06 February 2007 For release at 07.00 Feb 6th 2007 ADVENTIS GROUP PLC ACQUISITION OF LEAPFROG MEDICAL COMMUNICATIONS LTD Adventis Group plc ( "Adventis" or the "Company", ticker ATG), the specialistmultimedia and marketing group, is pleased to announce that it has acquiredLeapFrog Medical Communications Limited ("LeapFrog"), a leading medicaleducation company, for a total maximum consideration of £2.65 million. The total consideration will be satisfied by the payment of initialconsideration of £1.306 million, payable as to £0.874 million in cash and £0.432million by the issue of 975,169 new ordinary shares in Adventis ("New OrdinaryShares"), and by deferred consideration of £0.72 million payable in tranches of£0.24 million on each of the first, second and third anniversaries of theacquisition. Each deferred consideration tranche will be satisfied as to 60 percent in cash and as to 40 per cent payable in new ordinary shares in Adventis.There is further deferred consideration payable of up to £0.624 million, basedon the achievement of certain profit growth related criteria over the followingthree years to be satisfied annually according to performance as to 50 per centin cash and 50 per cent payable in new ordinary shares in Adventis. LeapFrog, whose clients include, GSK, Pfizer, MSD, Roche and Novartis, wasestablished in 2001. It provides a range of medical education programmes to thehealthcare industry, promotional aids for sales representatives and alsoinitiates PR campaigns aimed at healthcare professionals and consumers forimproving clients' product brand awareness. For the year ended 30 November 2006,LeapFrog reported audited turnover of approximately £1.57 million and pre-taxprofit of approximately £0.39 million. Net assets at that date amounted toapproximately £0.25 million. Tim Schofield and Gail Rowe, LeapFrog's principaldirectors, will remain with the company following the acquisition. The acquisition will create one of the industry's top three pharmaceuticalindustry service providers, becoming part of an enlarged Healthcare servicesdivision embracing Affiniti Advertising, acquired in 2005, and RoundhouseHealthAd, acquired in 2006. The addition of LeapFrog to Affiniti and Roundhouse creates a formidable,award-winning team in the Adventis Healthcare division, with over 50 employeesworking in centralised premises in the Thames Valley. The enlarged Healthcareservices operations, whose other clients include Boehringer Ingelheim, Allergan,Baxter and Merck Serono, will have the capability to provide a complete range ofintegrated marketing services, from medical education, to advertising to newmedia. It will also provide the opportunity for an increased level ofcross-selling and the ability to provide multinational clients with a greaterlocal understanding of target markets service. Application has been made for the admission to AIM of the New Ordinary Shares,which will rank pari passu with the Company's existing issued ordinary shares,and dealings are expected to commence on 9th February 2007. Charles Phillpot, CEO, Adventis Group, said: "We will now be one of the fewcompanies in the industry to offer a full service marketing capability and theability to handle larger and more complex campaigns for clients. We are nowamong the top three players in two of our three chosen market sectors." Tim Schofield and Gail Rowe said: "We see joining forces with the two topcreative agencies in our industry as a unique way of adding value to ourclients. Being able to address their various needs within one group will be atremendous bonus for us all." ENDS Enquiries: Adventis Group Plc Charles Phillpot, CEO 020 7034 4750 Peter Linnell, Finance Director & Company Secretary 020 7034 4795 Adventis Financial PR Chris Steele 020 7034 4759 Peter Binns 020 7034 4760 Editor's Note: Adventis Group plc, provides a complete range of communications services,including corporate identity programmes, advertising campaigns, media andplanning and buying, literature, public relations, packaging, exhibitions,research and planning, interiors signage and digital media. The group employs145 staff in London and the southeast. Adventis has two other divisions focusing on providing a range of services tothe property and financial sectors. Adventis Group was admitted to AIM in 2004,mainly operating as a media and marketing services provider to the propertysector. LeapFrog becomes the group's ninth operating company. www.adventis.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Dec 20187:04 amRNSCorporate and Project Update
3rd Dec 20187:00 amRNSExercise of Danube Petroleum Option
3rd Dec 20187:00 amRNSCompletion of Investment in Rathlin Energy
22nd Nov 201812:00 pmRNSUpdate on Upcoming Drilling at Reabold California
16th Nov 20185:00 pmRNSNotice of AGM
13th Nov 20187:00 amRNSUpdate on Wick and Colter
5th Nov 20187:00 amRNSInvestment in Rathlin Energy (UK) Ltd
2nd Nov 20187:00 amRNSReabold California - Operational Update
26th Oct 20187:00 amRNSFarm-out of Curlew-A Appraisal Well
25th Oct 20187:00 amRNSDanube Petroleum Investment Update
16th Oct 201811:43 amRNSUpdate on VG-3 Well, California
28th Sep 20187:00 amRNSRig Contract Signed for Wick and Colter
27th Sep 20187:00 amRNSHalf-year Report
24th Sep 20187:00 amRNSDanube Petroleum Investment Update
21st Sep 20189:35 amRNSAndalas Farm-in to Colter
20th Sep 20187:51 amRNSReplacement: Update on Reabold California
20th Sep 20187:00 amRNSUpdate on Reabold California
18th Sep 20187:00 amRNSInvestor Evening Presentation
17th Sep 20187:01 amRNSOperational Update on Wick
17th Sep 20187:00 amRNSAppointment of Nomad and Board Changes
13th Sep 20187:00 amRNSHolding(s) in Company
6th Sep 20182:26 pmRNSHolding(s) in Company
5th Sep 20183:34 pmRNSReplacement: Placing to raise £4.8 million
5th Sep 20181:26 pmRNSPlacing to raise £4.8 million
30th Aug 20187:00 amRNSUpdate on California - Discovery at VG-3 Well
28th Aug 201811:00 amRNSUpdate on Reabold California
20th Aug 20187:00 amRNSUpdate on Reabold California
16th Aug 20189:13 amRNSParta Information Memorandum
13th Aug 20187:00 amRNSUpdate on Reabold California
2nd Aug 20181:08 pmRNSHolding(s) in Company
30th Jul 20187:00 amRNSUpdate on Reabold California
25th Jul 20188:22 amRNSUpdate on Colter and Wick Projects
11th Jul 20189:58 amRNSParta - Independent Evaluation Results
5th Jul 20185:09 pmRNSHolding(s) in Company
29th Jun 201812:56 pmRNSResult of GM, and Acquisition of Gaelic Resources
29th Jun 20187:00 amRNSAnnual Report and Financial Statements 2017
22nd Jun 20184:44 pmRNSGeneral Meeting
15th Jun 201810:10 amRNSCompany Presentation
14th Jun 20187:00 amRNSAcquisition of Gaelic Resources and Notice of GM
4th Jun 20187:00 amRNSCPR on Corallian owned Oulton Appraisal Project
30th May 201812:38 pmRNSFinal tranche of investment in Corallian Energy
29th May 20182:02 pmRNSHolding(s) in Company
23rd May 20183:56 pmRNSCorallian 30th Seaward Licensing Round Award
15th May 20187:00 amRNSUpdate on Colter and Wick Projects
3rd Apr 20185:03 pmRNSTotal Voting Rights
3rd Apr 20183:35 pmRNSHolding(s) in Company
28th Mar 20189:46 amRNSFirst tranche of investment in Danube Petroleum
27th Mar 20183:45 pmRNSHolding(s) in Company
22nd Mar 201812:49 pmRNSHolding(s) in Company
21st Mar 20185:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.